Lions Research Labs

BPC-157/TB-500 Blend 10/10mg – Sky – SALE!

$85.00

This was originally purchased from Sky Peptides.  We are closing out at below cost the stock we didn’t need for our research projects. By purchasing, you are certifying and agreeing that you are purchasing for Research Use Only.

In stock

Category:

Description

Opinion Only.  Not for Medical Reference.  Written by Nevin Pratt

BPC-157

The FDA is meeting with the Pharmacy Compounding Advisory Committee (PCAC) on 7/23/26 to evaluate BPC-157 for the treatment of ulcerative colitis.

BPC is for soft tissue injury repair.  Half life 6-8 hrs.  Local injection at an injury site is best, but systemic (in the stomache area) works quite well too. People often mix this with TB-500 in the same vial, but I recommend against that.  Those two peptides have a different PH and a different half life.  Also different optimal dosing schedules.  Keep them separate.  A study on using BPC-157 for regeneration can be found here.

BPC-157 significantly stimulates epigenic change in over 100 types of genes, and does so very quickly.  It’s biggest effect is in stimulating angiogenesis, or the building of capillaries and veins, which in turn helps growth and repair factors flow to damaged tissue.  The way it does that is through influencing the genes that transcript nitric-oxide use.  It improves how your body utilizes nitric oxide that’s existing, and how your body makes more nitric oxide more efficiently.

Here are a couple of Youtube short videos on it.  The first is a Joe Rogan interview, and the second is from a well-known Stanford University professor, Dr. Andrew Huberman:

https://www.youtube.com/shorts/EVejn72GgQo
https://www.youtube.com/shorts/kOUvJVD_78U

Dr. Trevor Bachmeyer calls it a “forever peptide”, to be taken daily, and talks extensively about BPC-157 in this video:

https://youtu.be/nRi9GqTfGqY?si=bh2tuRTmX64_awQW

Here are some studies on it:

https://pubmed.ncbi.nlm.nih.gov/34267654/
https://pubmed.ncbi.nlm.nih.gov/40756949/

I believe that the claim that some have made regarding BPC-157 enabling cancer growth to be false.  In a cancer study, here is an article showing that in vitro, BPC-157 stopped human melanoma cell growth and reduced VEGF signaling. https://journals.lww.com/melanomaresearch/citation/2004/08000/bpc_157_inhibits_cell_growth_and_vegf_signalling.50.aspx.  And in mice with colon cancer cachexia, BPC-157 reduced muscle wasting and prolonged survival:  https://pubmed.ncbi.nlm.nih.gov/29898649/

Dosage: 300mcg to 600mcg daily.
5mg vial with 2cc BAC = 20 units daily = 500mcg/dose.
10mg vial with 2cc BAC = 10 units daily = 500mcg/dose.
10mg vial with 3cc BAC = 10 units for 333mcg.

If you can tolerate daily injections, then inject BPC-157 daily, and TB-500 every 3 to 5 days.

TB-500

Soft tissue injury repair.  Systemic injection. There’s evidence that it can repair fibrotic heart muscle tissue after a heart attack.

TB-500 might help for kidney repair.  It is highly angiogenic, and the kidney’s are very vascular in nature.

The FDA is meeting with the Pharmacy Compounding Advisory Committee (PCAC) on 7/23/26 to evaluate TB-500 forwound healing.

In 2010 there was a study in Circulation that TB-500, following an MI (myocardial infarction, or heart attack) in mice resulted in reversal of the fibrotic tissue damage of the MI.

2012, Journal of Pharmacology and Therapeutics showed TB-500 promotes wound healing.

Annals of the New York Academy of Sciences shows TB-500 inhibits migration and invasion of gleoblastoma cells (gloeblastoma is a highly aggressive brain cancer).  In doing so, it interferes with the same actin dynamics that cancer cells use to mestastasize.

TB-500 might also help with ED, by reversing penile fibrotic tissue damage.  Thepenile fibrotic tissue damage can be because of diabetes, high blood pressure, infections, or other various vascular problems.

It also helps with the repair of damaged nerves, by promoting the growth and projections of neurites.

The angiogenic properties of TB-500 can help with diabetic ulcers.

Some people will combine this with BPC-157, in the same syringe.  I recommend against that. BPC and TB have different PH’s, and different half lifes.  They also have different “optimal” dosing schedules. So, inject them separately. However, the two are definitely synergistic in their effect, which means you should put them both in your stack.  Some people refer to this as the “Wolverine Stack”, because of how well they heal together.

Dosage: I have concluded that TB-500 is best dosed in larger “pulses”, not smaller daily microdoses.  Smaller doses might not be adequate for proper cell signaling.  An analogy is like trying to hear a whisper in a noisy room.  If you want to be heard, you need to turn the volume up.

I think I prefer 10mg vial with 1cc BAC, then take 50 units (which would be 5mg) every 5 days.  This amount results in using 1/2 of a 10mg vial with each injection.  Do this for (maybe) four of the 10mg vials (40 days), then rest for about 4 weeks.